- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Keratopathy.
Displaying page 1 of 1.
EudraCT Number: 2010-024328-53 | Sponsor Protocol Number: HULPOFT-2010-01 | Start Date*: 2012-05-14 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz | ||
Full Title: Phase IIa clinical trial to determine the feasibility and safety of using autologous expanded stem cell (ASC) from fat in the treatment of keratopathy associated with bilateral limbic insufficiency | ||
Medical condition: Keratopathy associated with bilateral limbic insufficiency. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002389-13 | Sponsor Protocol Number: | Start Date*: 2005-11-23 |
Sponsor Name:Moorfields Eye Hospital | ||
Full Title: Endothelial Lamellar Keratoplasty (ELK) with Tisseel adhesive. | ||
Medical condition: Corneal endothelial failure, from Fuchs' corneal endothelial dystrophy, aphakic and pseudophakic bullous keratopathy and other causes. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001841-23 | Sponsor Protocol Number: I.2016.010 | Start Date*: 2016-11-16 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A multicenter, randomized, open-label, two-arms phase I/II clinical trial to asses efficacy and safety of cord blood eye drops in neurotrophic keratopathy | |||||||||||||
Medical condition: Neurotrophic Keratitis, stage 2 or 3 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001013-39 | Sponsor Protocol Number: PTC124-GD-028-ANI | Start Date*: 2022-04-14 |
Sponsor Name:PTC Therapeutics, Inc | ||
Full Title: A Phase 2, Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Ataluren (PTC124) for the Treatment of Nonsense Mutation Aniridia | ||
Medical condition: Nonsense Mutation Aniridia | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2012-004605-27 | Sponsor Protocol Number: Occhuiosecco | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA | |||||||||||||
Full Title: Study Prospective Randomized Controlled Double-Blind: Comparison of tear substitute (Siccafluid) and Autologous Serum in Dry Eye Disease | |||||||||||||
Medical condition: Dry eye disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002475-34 | Sponsor Protocol Number: REC0559-B-001 | Start Date*: 2020-03-03 | |||||||||||
Sponsor Name:Recordati Rare Diseases | |||||||||||||
Full Title: Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients | |||||||||||||
Medical condition: Neurotrophic Keratitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000598-30 | Sponsor Protocol Number: CS001-EU01 | Start Date*: 2012-03-06 | |||||||||||
Sponsor Name:Cellseed France S.A.R.L. | |||||||||||||
Full Title: MULTICENTER STUDY OF CULTURED AUTOLOGOUS ORAL MUCOSAL EPITHELIAL CELL-SHEET (CAOMECS) TRANSPLANTATION TO PATIENTS WITH TOTAL LIMBAL STEM CELL DEFICIENCY | |||||||||||||
Medical condition: Limbal Stem Cell Deficiency of the Eye | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Ongoing) AT (Prematurely Ended) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002515-34 | Sponsor Protocol Number: CMG012022 | Start Date*: 2023-03-28 | |||||||||||
Sponsor Name:Czech Myeloma Group | |||||||||||||
Full Title: Phase 2 study of belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma | |||||||||||||
Medical condition: The study will enroll adult participants with RRMM who have been previously treated with at least 1 prior line of therapy, and who have documented disease progression during, or after, their most r... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004001-32 | Sponsor Protocol Number: EMN27 | Start Date*: 2021-01-29 | |||||||||||
Sponsor Name: European Myeloma Network – EMN | |||||||||||||
Full Title: A phase 2 study of Belantamab Mafodotin in patients with relapsed or refractory AL amyloidosis | |||||||||||||
Medical condition: relapsed or refractory AL amyloidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) DE (Ongoing) GR (Ongoing) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001942-39 | Sponsor Protocol Number: EAE128 | Start Date*: 2022-10-24 | |||||||||||
Sponsor Name:Hellenic Society of Hematology (EAE) | |||||||||||||
Full Title: A phase 1/2, dose and schedule evaluation study to investigate the safety and clinical activity of belantamab mafodotin administered in combination with lenalidomide, dexamethasone and nirogacestat... | |||||||||||||
Medical condition: Newly diagnosed patients with multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.